- If you are wondering whether HCA Healthcare’s current share price reflects its true worth, you are not alone. This article is designed to help you weigh what you are actually paying for.
- The stock last closed at US$532.58, with returns of 6.1% over 30 days and 13.2% year to date, while the 1 year return stands at 70.5% and the 3 year return at 114.0%.
- Over the past year, HCA Healthcare has been in the spotlight for its role as a major US hospital operator and for ongoing discussion around healthcare capacity and access. This has kept investor attention firmly on the group. Broader conversations about hospital networks, reimbursement frameworks and capital investment needs have also shaped how the market is thinking about large healthcare providers like HCA.
- Simply Wall St’s valuation checks currently give HCA Healthcare a score of 5 out of 6. Next, we will walk through the key methods behind that number, before finishing with a way to look at valuation that can tie all these pieces together for you.
Approach 1: HCA Healthcare Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today’s dollars, giving an estimate of what the entire business might be worth right now.
For HCA Healthcare, the model used is a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The latest twelve month free cash flow is about US$7.4b. Analysts provide explicit estimates for the next few years, and beyond that Simply Wall St extrapolates free cash flows, with the 2030 projection at US$8.3b and further estimates extending out to 2035. Each of these future cash flows is discounted back using a required rate of return to reflect risk and the time value of money.
Adding up those discounted values produces an estimated intrinsic value of US$890.18 per share. Compared with the recent share price of US$532.58, the model implies HCA Healthcare is trading at about a 40.2% discount to this estimate. On this measure alone, the stock appears materially undervalued.
Result: UNDERVALUED
Our Discounted Cash Flow (DCF) analysis suggests HCA Healthcare is undervalued by 40.2%. Track this in your watchlist or portfolio, or discover 47 more high quality undervalued stocks.
Approach 2: HCA Healthcare Price vs Earnings
For a profitable company like HCA Healthcare, the P/E ratio is a straightforward way to think about valuation because it links what you pay today to the earnings the business is already generating. Investors usually accept a higher or lower P/E depending on what they expect for future earnings growth and how risky those earnings appear to be, so there is no single “right” P/E that fits every company.
HCA Healthcare currently trades on a P/E of 17.5x. That sits below both the peer average of 18.6x and the broader Healthcare industry average P/E of 22.1x. Simply Wall St also calculates a proprietary “Fair Ratio” for HCA Healthcare of 33.8x, which is the P/E level suggested after factoring in elements like earnings growth characteristics, profit margins, size and risk profile. This Fair Ratio can be more informative than a simple comparison with peers or the industry because it is tailored to the company’s own fundamentals rather than broad group averages.
With the Fair Ratio of 33.8x well above the current P/E of 17.5x, this framework points to HCA Healthcare trading below the level implied by these inputs.
Result: UNDERVALUED
P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 18 top founder-led companies.
Upgrade Your Decision Making: Choose your HCA Healthcare Narrative
Earlier we mentioned that there is an even better way to understand valuation. Let us introduce Narratives, which let you attach a clear story about HCA Healthcare to your own numbers by linking your view of its future revenue, earnings and margins to a forecast and then to a fair value that you can easily compare with today’s share price. All of this is available within the Simply Wall St Community page, where Narratives are updated as new news or earnings arrive and where different investors can hold very different views. For example, one HCA Narrative on the platform currently assumes a fair value of about US$629.14 per share, while another sits closer to about US$543.05. This shows you in one glance how two people can look at the same company, plug in different assumptions, and reach different conclusions about whether the current price looks expensive or attractive for their own decision making.
Do you think there's more to the story for HCA Healthcare? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com